AI vs. MRI: the race to spot Chemo's hidden heart damage
NCT ID NCT07093918
Summary
This study aims to see if new artificial intelligence (AI) software can improve heart scans for people receiving chemotherapy. It will compare two AI systems against standard heart ultrasound and cardiac MRI in 120 patients to see which method is most accurate at detecting early signs of chemotherapy-related heart damage. The goal is to find a faster, more reliable way to monitor heart health during cancer treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOTOXICITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.